Hiroshima, Japan

Shunshuke Ito

This inventor holds 1 USPTO granted patent. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shunshuke Ito. Retrieved from https://idiyas.com/inventor/shunshuke-ito

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shunshuke Ito: Pioneering Innovations in Pharmaceuticals

Introduction: Shunshuke Ito, an esteemed inventor hailing from Hiroshima, JP, has made significant contributions to the world of pharmaceuticals through his groundbreaking inventions.

Latest Patents: Shunshuke Ito holds a notable patent titled "Glycyrrhetic acid derivatives and use thereof." This patent showcases a glycyrrhetic acid derivative with a specific formula, offering a novel pharmaceutical agent for various applications in the medical field.

Career Highlights: With an impressive portfolio of 1 patent under his name, Shunshuke Ito has demonstrated a keen ability to innovate and create solutions that have the potential to enhance healthcare practices and treatments. His dedication to research and development is evident in the quality of his patented work.

Collaborations: Throughout his career, Shunshuke Ito has collaborated with talented individuals in the industry, including Masayasu Kurono and Ryoichi Unno. These partnerships have led to the exchange of innovative ideas and the successful realization of projects that push the boundaries of pharmaceutical innovation.

Conclusion: In conclusion, Shunshuke Ito stands as a beacon of creativity and ingenuity in the world of invention, with a legacy that continues to inspire future generations of inventors and innovators. His contributions to pharmaceutical advancements exemplify his commitment to driving progress and improving the quality of healthcare globally.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…